Hyaluronan preserves peritoneal membrane transport properties

Area of Science:

• Peritoneal dialysis research
• Membrane transport phenomena
• Biomaterial applications in medicine

Background:

• Single dwell studies indicated intraperitoneal (i.p.) hyaluronan (HA) increases peritoneal fluid removal by decreasing absorption rate.
• The impact of repeated HA use on peritoneal membrane transport characteristics required further investigation.

Purpose of the Study:

• To investigate the effect of repeated intraperitoneal hyaluronan administration on peritoneal membrane transport characteristics in rats.
• To determine if HA can ameliorate changes in peritoneal membrane function induced by hypertonic glucose dialysis solutions.

Main Methods:

• Rats received daily i.p. injections of 4.25% glucose dialysis solution with or without 0.025% HA for one week.
• A 4-hour dwell study with volume marker and frequent sampling was conducted 48 hours after the last injection.
• Peritoneal fluid absorption, lymphatic absorption, and solute transport rates were measured and compared between HA-treated, non-HA-treated, and control groups.

Main Results:

• Repeated exposure to hypertonic glucose solution increased peritoneal fluid absorption and solute transport rates.
• Hyaluronan treatment significantly increased net ultrafiltration and decreased peritoneal fluid absorption rate compared to the non-HA group.
• Solute transport rates were generally lower in the HA group compared to the non-HA group, with protein transport being significantly lower than in controls.

Conclusions:

• Repeated exposure to hypertonic glucose dialysis solution increases peritoneal solute and fluid absorption rates, indicating a highly permeable membrane.
• Repeated i.p. hyaluronan administration ameliorates these changes, suggesting a protective effect on the peritoneal membrane.
• Hyaluronan did not significantly influence direct peritoneal lymphatic absorption rates.